Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Inhalte:

  • => Welche Forschungsthemen werden an der Medizinischen Universität bearbeitet?.
  • => Wer ist daran beteiligt und welche Methoden werden angewandt?.
  • => Welche Fördergeber unterstützen welche Projekte?.
  • => Wo werden Forschungsergebnisse publiziert?.

Facts and Figures: 2.398 Forscher*innenprofile (davon 883 mit ORCID-ID), 7.050 Forschungsprojekte, 140.198 Publikationen, Posters und Vorträge, 55.694 Volltextlinks (davon Volltext frei zugänglich: > 23.838 (Open Access) )

Aktuelle Zitierungen im Web of Science: 1.535.517, davon 3.038 citation classics (>=100 Zitierungen) Summe Altmetrics Score: 213.255

Aktuell durch Fördergeber bewilligte Forschungsprojekte:

Antigenpräsentation und Immunopathologie in Herzinsuffizienz.
Projektleitung: Sattler Susanne
Laufzeit: 01.12.2022 - 30.11.2026
Geldgeber: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung

ActiHeal: Rolle des ribosomalen Proteins S6 in der Heilung
Projektleitung: Kamolz Lars-Peter
Laufzeit: 01.06.2023 - 31.05.2025
Geldgeber: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung

> Weitere neue Projekte

Die aktuellsten Publikationen in "Top-Journalen" (Top 20 % Impact Ranking):


27.03.2023:

Pereira, MP; Weisshaar, E; Halvorsen, JA; Wallengren, J; Legat, FJ; Garcovich, S; Savk, E; Reich, A; Bozek, A; Lvov, A; Bobko, S; Metz, M; Streit, M; Misery, L; Brenaut, E; Serra-Baldrich, E; Goncalo, M; Szepietowski, JC; Augustin, M; Nau, T; Zeidler, C; Staender, S Chronic prurigo: Insufficient disease control in spite of high healthcare usage
J EUR ACAD DERMATOL. 2023; Doi: 10.1111/jdv.18903
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Chernyshov, PV; Finlay, AY; Tomas-Aragones, L; Steinhoff, M; Manolache, L; Pustisek, N; Dessinioti, C; Svensson, A; Marron, SE; Bewley, A; Salavastru, C; Dreno, B; Suru, A; Koumaki, D; Linder, D; Evers, AWM; Abeni, D; Augustin, M; Salek, SS; Nassif, A; Bettoli, V; Szepietowski, JC; Zouboulis, CC Quality of life measurement in rosacea. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa
J EUR ACAD DERMATOL. 2023; Doi: 10.1111/jdv.18918
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Hohenschurz-Schmidt, D; Draper-Rodi, J; Vase, L; Scott, W; McGregor, A; Soliman, N; MacMillan, A; Olivier, A; Cherian, CA; Corcoran, D; Abbey, H; Freigang, S; Chan, J; Phalip, J; Sorensen, LN; Delafin, M; Baptista, M; Medforth, NR; Ruffini, N; Andresen, SS; Ytier, S; Ali, D; Hobday, H; Santosa, AANAA; Vollert, J; Rice, ASC Blinding and sham control methods in trials of physical, psychological, and self-management interventions for pain (article II): a meta-analysis relating methods to trial results
PAIN. 2023; 164(3): 509-533. Doi: 10.1097/j.pain.0000000000002730
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Odler, B; Riedl, R; Gauckler, P; Shin, JI; Leierer, J; Merkel, PA; St Clair, W; Fervenza, F; Geetha, D; Monach, P; Jayne, D; Smith, RM; Rosenkranz, A; Specks, U; Stone, JH; Kronbichler, A Risk factors for serious infections in ANCA-associated vasculitis
ANN RHEUM DIS. 2023; Doi: 10.1136/ard-2022-223401
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Ahangari, F; Price, NL; Malik, S; Chioccioli, M; Barnthaler, T; Adams, TS; Kim, J; Pradeep, SP; Ding, SZ; Cosmos, CC; Rose, KAS; McDonough, JE; Aurelien, NR; Ibarra, G; Omote, N; Schupp, JC; DeIuliis, G; Nunez, JAV; Sharma, L; Ryu, C; Cruz, CSD; Liu, XR; Prasse, A; Rosas, I; Bahal, R; Fernandez-Hernando, C; Kaminski, N microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis
JCI INSIGHT. 2023; 8(4): e158100 Doi: 10.1172/jci.insight.158100
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Hohenschurz-Schmidt, D; Draper-Rodi, J; Vase, L; Scott, W; McGregor, A; Soliman, N; MacMillan, A; Olivier, A; Cherian, CA; Corcoran, D; Abbey, H; Freigang, S; Chan, JSC; Phalip, J; Sorensen, LN; Delafin, M; Baptista, M; Medforth, NR; Ruffini, N; Andresen, SS; Ytier, S; Ali, D; Hobday, H; Santosa, AANAA; Vollert, J; Rice, ASC Blinding and sham control methods in trials of physical, psychological, and self-management interventions for pain (article I): a systematic review and description of methods
PAIN. 2023; 164(3): 469-484. Doi: 10.1097/j.pain.0000000000002723
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Dejaco, C; Ramiro, S; Touma, Z; Bond, M; Soowamber, M; Sanchez-Alvarez, C; Langford, CA What is a response in randomised controlled trials in giant cell arteritis?
ANN RHEUM DIS. 2023; Doi: 10.1136/ard-2022-223751
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Buttia, C; Llanaj, E; Raeisi-Dehkordi, H; Kastrati, L; Amiri, M; Mecani, R; Taneri, PE; Ochoa, SAG; Raguindin, PF; Wehrli, F; Khatami, F; Espinola, OP; Rojas, LZ; de Mortanges, AP; Macharia-Nimietz, EF; Alijla, F; Minder, B; Leichtle, AB; Luethi, N; Ehrhard, S; Que, YA; Fernandes, LK; Hautz, W; Muka, T Prognostic models in COVID-19 infection that predict severity: a systematic review
EUR J EPIDEMIOL. 2023; Doi: 10.1007/s10654-023-00973-x
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Zewinger, S; Reiser, J; Jankowski, V; Alansary, D; Hahm, E; Triem, S; Klug, M; Schunk, SJ; Schmit, D; Kramann, R; Korbel, C; Ampofo, E; Laschke, MW; Selejan, SR; Paschen, A; Herter, T; Gaul, S; Silbernagel, G; Sester, M; Sester, U; Assmann, G; Bals, R; Kostner, G; Jahnen-Dechent, W; Menger, MD; Rohrer, L; Marz, W; Bohm, M; Jankowski, J; Kopf, M; Latz, E; Niemeyer, BA; Fliser, D; Laufs, U; Speer, T Reply to: Apolipoprotein C3 induces inflammasome activation only in its delipidated form
NAT IMMUNOL. 2023; Doi: 10.1038/s41590-023-01424-1
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Heller, S; Battelino, T; Bailey, TS; Pieber, TR; Hovelmann, U; Plum-Morschel, L; Melgaard, AE; Aronson, R; DiMeglio, LA; Johansen, T; Danne, T Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes
DIABETES OBES METAB. 2023; Doi: 10.1111/dom.14987
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Giesen, N; Busch, E; Schalk, E; Beutel, G; Ruthrich, MM; Hentrich, M; Hertenstein, B; Hirsch, HH; Karthaus, M; Khodamoradi, Y; Koehler, P; Kruger, W; Koldehoff, M; Krause, R; Mellinghoff, SC; Penack, O; Sandherr, M; SeggeWiss-Bernhardt, R; Spiekermanny, K; Sprute, R; Stemler, J; Weissinger, F; Woermann, B; Wolf, HH; Cornely, OA; Rieger, CT; von Lilienfeld-Toal, M AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaXis and therapy in light of the omicron variants
EUR J CANCER. 2023; 181: 102-118. Doi: 10.1016/j.ejca.2022.11.030
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Donskov, AO; Mackie, SL; Hauge, EM; Toro-Gutierrez, CE; Hansen, IT; Hemmig, AK; Van der Maas, A; Gheita, T; Nielsen, BD; Douglas, KMJ; Conway, R; Rezus, E; Dasgupta, B; Monti, S; Matteson, EL; Sattui, SE; Matza, M; Ocampo, V; Gromova, M; Grainger, R; Bran, A; Appenzeller, S; Goecke, A; Colman, N; Keen, HI; Kuwana, M; Gupta, L; Salim, B; Harifi, G; Erraoui, M; Ziade, N; Al-Ani, NA; Ajibade, A; Knitza, J; Frolund, L; Yates, M; Pimentel-Quiroz, VR; Lyrio, AM; Sandovici, M; Van der Geest, KSM; Helliwell, T; Brouwer, E; Dejaco, C; Keller, KK An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists
RHEUMATOLOGY. 2023; Doi: 10.1093/rheumatology/keac713
Web of Science PubMed FullText FullText_MUG

 

23.03.2023:

Adelsmayr, G; Janisch, M; Kaufmann-Bühler, AK; Holter, M; Talakic, E; Janek, E; Holzinger, A; Fuchsjäger, M; Schöllnast, H CT texture analysis reliability in pulmonary lesions: the influence of 3D vs. 2D lesion segmentation and volume definition by a Hounsfield-unit threshold.
Eur Radiol. 2023; Doi: 10.1007/s00330-023-09500-8
PubMed FullText FullText_MUG

 

21.03.2023:

Azabdaftari, A; Sczakiel, HL; Danyel, M; Kohlmaier, B; Mache, CJ; Stalke, A; Pfister, ED; Thumfart, J; Henning, S; Knisely, AS; Bufler, P Biallelic known and novel DCDC2 variants in cholestatic liver disease: phenotype-genotype observations in four children.
Liver Int. 2023; Doi: 10.1111/liv.15563
PubMed FullText FullText_MUG

 

21.03.2023:

Agrafiotis, E; Mayer, C; Grabenwöger, M; Zimpfer, D; Regitnig, P; Mächler, H; Holzapfel, GA Global and local stiffening of ex vivo-perfused stented human thoracic aortas: A mock circulation study.
Acta Biomater. 2023; Doi: 10.1016/j.actbio.2023.02.028
PubMed FullText FullText_MUG

 

21.03.2023:

Pukaluk, A; Wolinski, H; Viertler, C; Regitnig, P; Holzapfel, GA; Sommer, G Changes in the microstructure of the human aortic adventitia under biaxial loading investigated by multi-photon microscopy.
Acta Biomater. 2023; Doi: 10.1016/j.actbio.2023.02.027
PubMed FullText FullText_MUG

 

> Weitere aktuelle Publikationen in Top-Journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)


Med Uni Graz publications1 were assigned quintiles according to the normalized2 Clarivate’s Journal Impact Factor of the journal at the time of publication.


Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).


JIFnorm: Proportional Distribution


Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.


JIFnorm: Absolut Impact


1 This analysis considered only publications categorized as full papers/original articles.

2 IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in WoS category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.

© Med Uni Graz Impressum